They've got a $624m deal in their pocket, a portfolio of cancer treatments that are making waves in clinical trials and a team that combines scientific acumen with astute commercial strategy. That's why we've decided to feature Scancell Holdin
Hello Investors. On the Slingshot today we're discussing an emerging darling of the British automotive industry, manufacturer of carbon ceramic disc brakes Surface Transforms. They count the likes of Aston Martin, Lamborghini, Porsche, Mclaren